Skip to main content

Advertisement

SpringerLink
Log in

Burden of fungal infections in Algeria

  • Original Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

We report for the first time in Algeria and provide burden estimates. We searched for existing data and estimated the incidence and prevalence of fungal diseases based on the population at risk and available epidemiological data. Demographic data were derived from the National Office of Statistics (Office National des Statistiques: ONS), World Health Organization (WHO), The Joint Nations Programme on HIV/AIDS (UNAIDS) and national published reports. When no data existed, risk populations were used to estimate frequencies of fungal infections, using previously described methodology. Algeria has 40.4 million inhabitants, and probably at least 568,900 (1.41%) of Algerians have a serious fungal infection each year. Recurrent vulvovaginal candidiasis (485,000) and fungal asthma (72,000) are probably the commonest problems, as there are over 1 million adult asthmatics. Candidaemia is estimated in 2,020 people, invasive aspergillosis in 2,865 people, and intra-abdominal candidiasis in 303 people; these are the most common life-threatening problems. AIDS is uncommon, but cancer is not (45,000 new cases of cancer including 1,500 in children), nor is COPD (an estimated 317,762 patients, of whom 20.3% are admitted to hospital each year). A focus on improving the diagnosis and epidemiological data related to fungal infection is necessary in Algeria.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abid L Organisation actuelle du système national de santé et perspectives.www.sante.dz/colloque/docs/03_organisation_systeme_s_abid.pdf

  2. World Health Organization (WHO). http://www.who.int/countries/dza/en/country_profil

  3. Zitouni M (2014) Colloque international sur les politiques de santé. http://www.ands.dz/colloque/docs/sante_proximite_rabia.pdf. Accessed 02 Aug 2016

  4. Bendjelloul M, Boucherit-Otmania Z, Boucherita K (2016) Study of strains of Candida spp. Isolated from catheters in UHC of Oran (Algeria). Identification and antifungal susceptibility. J Mycol Med 18:S1156–S5233. doi:10.1016/j.mycmed.2016.02.022

  5. Arrache D, Madani KH, Achir I, Younsi N, Zebdi A, Bouahri L, Chaouche F, Hamrioui B (2016) Fongémies diagnostiquées au laboratoire de parasitologie-mycologie du CHU Mustapha d’Alger, Algérie (2004—2014). J Mycol Med 237–238. doi:10.1016/j.mycmed.2015.06.049

  6. Chekiri M (2013) Aspergillose et Candidose invasive dans deux services à haut risque au CHU -Blida. Doctorat thesis 2013 -Pharmacydepartment -Blida university –ALGERIA

  7. Arrache D, Zait H, Bouahri L, Bouhellal H, Madani K, Matougui S, Hamiche R, Hamrioui B (2016) Cryptococcose chez les patients non VIH: quatre nouvelles observations sur sarcoïdose, polyarthrite rhumatoïde, cirrhose hépatique et transplantation rénale (2016). J Mycol Med 26, e19. doi:10.1016/j.mycmed.2016.04.043

  8. Boucherit-Atmani Z, Seddiki SML, Boucherit K, Sari-Belkharoubi L, Kunke D (2011) Candida albicans biofilms formed into catheters and probes and their resistance to amphotericin B. J Mycol Med 21:182–187. doi:10.1016/j.mycmed.2011.07.006

  9. Zait H, Madani K, Abed-Benamara M, Achir I, Hamrioui B (2008) Mycetoma in Algeria about two new cases. Review of cases reported between 1995 and 2005. J Mycol Med 18:116–122. doi:10.1016/j.mycmed.2008.04.001

  10. Official demographic data of the Algeria:http://www.ons.dz/img/pdf/demographie2015.pdf

  11. Zidouni N (2012) La place de la tuberculose dans les deux rives de la méditerranée : 8Th Thoracic Diseases Mediterranean Congress & 21 The National Meeting of Pneumology :https://fr.scribd.com/doc/96386408/prog-umpt-2012

  12. Khelafi R, Aissanou A, Tarsift S, Skander F (2011) Epidemiology of chronic obstructive pulmonary disease in Algiers. Rev Mal Respir 28:32–40. doi:10.1016/j.rmr.2010.06.026

  13. Asthmaestimates: http://www.sappalgeria.org/html/guide_asthme.html

  14. AIDS in Algeria :http://www.unaids.org/en/regionscountries/countries/algeria

  15. AML estimate http://www.radioalgerie.dz/news/fr/article/20150425/38291.html

  16. Renal transplant : www.algerie-focus.com/

  17. Polatli M, Ben Kheder A, Wali S, Javed A, Khattab A, Mahboub B, Iraqi G, Nejjari C, Taright S, Koniski ML, Rashid N, El Hasnaoui A (2012) BREATHE Study Group. Chronic obstructive pulmonary disease and associated healthcare resource consumption in the Middle East and North Africa: the BREATHE study. Respir Med 106:S75–S85. doi:10.1016/S0954-6111(12)70016-1

  18. CF estimate: http://www.algeriepatriotique.com/fr/article/

  19. Djeridane A, Djeridane Y, Ammar-Khodja A (2006) Epidemiological and aetiological study on tineapedis and onychomycosis in Algeria. Mycoses 49:190–196

  20. Benmezdad A, Moulahem T, Benyezzar M, Djaballah M, Beldjoudi W, Fendri AH (2012) Tinea capitis in the university hospital in Constantine (Algeria). J Mycol Med 22:354–356. doi:10.1016/j.mycmed.2012.09.002

  21. Ilham A, Touabti A (2012) Les onychomycoses au laboratoire de parasitologie CHU Sétif : étude sur dix ans. J Mycol Med 81-82. doi:10.1016/j.mycmed.2012.12.036

  22. Bendjaballah-Laliam A, Djazer H (2011) Teignes du cuir chevelu à l’ouest d’Alger (Wilaya de Tipasa) (2012). J Mycol Med 23:81. doi:10.1016/j.mycmed.2012.12.035

  23. Chelgham I, Belkhelfa S, Achachi S, Aissaoui I, Mohamdi N (2011) Les mycoses superficielles: à propos des cas diagnostiques dans la région des Aures (Batna)/ Algérie de 2002 à 2011. J Mycol Med 22:113. doi:10.1016/j.mycmed.2011.12.045

  24. Chekiri-Talbi, Denning D (2015) Etiological profile and epidemiology of tineacapitis in the region of Metidja (Blida) in Algeria. http://life-worldwide.org

  25. Benmezdad A, Moulahem T Profil fongique des mycoses superficielles diagnostiquées au laboratoire de parasitologie–mycologie du CHU de Constantine : Étude rétrospective : années 2011–2012–2013. J Mycol Med 25:243. doi:10.1016/j.mycmed.2015.06.063

  26. Oudainaa W, Biougnacha H, Rianea S, El Yaagoubila I, Tangia R, Ajdaea L, Agoumib A, Tliguib H (2011) Epidemiology of tineacapitis in outpatients at the Children’s Hospital in Rabat (Morocco). J Mycol Med 21:1–5. doi:10.1016/j.mycmed.2010.11.001

  27. Bendjaballah-Laliam A, Djazer H (2014) Epidemiologie des teignes du cuir chevelu de la banlieue de Tipasa, Algerie. J Mycol Med 24:141–143. doi:10.1016/j.mycmed.2014.02.008

  28. Neji S, Chakroun M, Dammak Y, Trabelsi H, Makni F, Cheikhrouhou F, Sellami H, Marrekchi S, Meziou J, Ayadi A (2012) Les mycoses superficielles : profil épidémiologique et mycologique des différents champignons isolés au CHU de Sfax (Tunisie). J Mycol Med 22:103–104. doi:10.1016/j.mycmed.2011.12.019

  29. Achachi S, Chelgham I, Belkhelfa S, Aissaoui I, Mohamdi N (2011) Teigne favique chez une adulte. J Mycol Med 22:113–114. doi:10.1016/j.mycmed.2011.12.046

  30. Haine-Madani K, Boukerzaza I, Hamrioui B (2013) Les otomycoses : épidémiologie et diagnostic au CHU Mustapha Bacha d’Alger. J Mycol Med 23:210. doi:10.1016/j.mycmed.2014.02.008

  31. Merad Y, Adjmi-Hamoudi H, Lansari T, Cassaing S (2016) Les otomycosesdermatophytiques: étude rétrospective de 2010 à 2015. J Mycol Med 26:e35–e36. doi:10.1016/j.mycmed.2016.04.078

  32. Merad Y, Adjmi-Hamoudi H, Lahmer K, Saadaoui E, Cassaing S, Berry A (2016) Les otomycoses chez les porteurs d’aides auditives: Etude rétrospective de 2010 à 2015. J Mycol Med 26:71. doi:10.1016/j.mycmed.2016.02.012

  33. Foxman B, Muraglia R, Dietz JP, Sobel JD, Wagner J (2013) Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey. J Low Genit Tract Dis 17:340–345

  34. Ryan-Wenger NA, Neal JL, Jones AS, Lowe NK (2010) Accuracy of vaginal symptom self-diagnosis algorithms for deployed military women. Nurs Res 59:2–10. doi:10.1097/NNR.0b013e3181c3b9dd

  35. Benaissaa S, Mehri N, Mansouri R, Bouchene Z (2011) Les mycoses oculaires et périoculaires, conduite diagnostique et thérapeutique, à propos de quelques cas. J Mycol Med 22:112. doi:10.1016/j.mycmed.2011.12.041

  36. Zaki SM, Denning DW (2016) The burden of serious fungal deseases in Egypt. http://life-worldwide.org/assets/uploads/files/Egypt.pdf

  37. Hadrich I, Makni F, Sellami H, Cheikhrouhou F, Sellami A, Bouaziz H, Hdiji S, Elloumi M, Ayadi A (2010) Invasive aspergillosis: epidemiology and environmental study in haematology patients (Sfax, Tunisia). Mycoses 53:443–447. doi:10.1111/j.1439-0507.2009.01710.x

  38. Saghrouni F, Ben Youssef Y, Gheitha, Bouabidc Z, Ben Abdeljelila J, Khammaria I, Fathallaha A, Khlifb A, Ben Saïda M (2011) Twenty-nine cases of invasive aspergillosis in neutropenic patients. J Mycol Med 41:657–662. doi:10.1016/j.medmal.2011.09.011

  39. Bouakba A (2012) La prévalence en Algérie de la BPCO estimée à près de 4% Moins de 10% des traitements utilisés sont conformes aux directives thérapeutiques actuelles http://www.vitaminedz.org/la-prevalence-en-algerie-de-la-bpco-estimee-a-pres-de-4/Articles_18300_796354_16_1.html

  40. Yan X, Li M, Jiang M, Zou L, Luo F, Jiang Y (2009) Clinical characteristics of 45 patients with invasive pulmonary aspergillosis: retrospective analysis of 1711 lung cancer cases. Cancer 115:5018–5025

  41. Guinea J, Torres-Narbona M, Gijon P, Munoz P, Pozo F, Pelaez T et al (2010) Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect 16:870–877

  42. National survey on the cancer in Algeria. http://www.sante.dz/cancer/plan_national_cancer.pdf

  43. Zait H, Arrache D, Madani K, Bentaiba K, Beradi K, Achir I, Bouhellal H, Matougui S, Amrane A, Zerouali H, Hamrioui B (2016) Vingt-quatre cas de cryptococcose diagnostiqués au laboratoire de parasitologie-mycologie du CHU Mustapha d’Alger 2002—2015. J Mycol Med 25:237. doi:10.1016/j.mycmed.2015.06.048

  44. Tattevin P (2012) Cinquièmes Journées internationales d’infectiologie de Sétif Algérie (2012). La Lettre de l’Infectiologue XXVII:4

  45. Lowe DM, Rangaka MX, Gordon F, James CD, Miller RF (2013) Pneumocystis jirovecii pneumonia in tropical and low and middle income countries: a systematic review and meta-regression. PLoS One 8(8), e69969

  46. Seddiki SML, Boucherit-Otmania Z, Boucherit K, Kunkel D Fungal infectivities of implanted catheters due to Candida sp. Biofilms formation and resistance. J Mycol Med 25:130–135. doi:10.1016/j.mycmed.2015.03.003

  47. Seghir A, Boucherit-Otmania Z, Belkherroubi-Saria L, Boucherit K (2014) Catheterization and fungal infection risk in the University Hospital of Tlemcen: epidemiology and susceptibility to antifungals. J Mycol Med 24:e179–e184. doi:10.1016/j.mycmed.2014.08.005

  48. Vergidis P, Clancy CJ, Shields RK, Park SY, Wildfeuer BN, Simmons RL, Nguyen MH (2016) Intra-abdominal candidiasis: the importance of early source control and antifungal treatment. PLoS One 11, e0153247. doi:10.1371/journal.pone.0153247

  49. Montravers P, Mira JP, Gangneux JP, Leroy O, Lortholary O (2011) A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive‐care units. Clin Microbiol Infect 17(7):1061–1067

  50. Zait H, Hamrioui B (2011) Pulmonary aspergilloma: about 39 cases. J Mycol Med 21:138–141

  51. Un million d’asthmatiques recensés en Algérie. Article in Algerian newspaper: 15 February 2014.http://www.radioalgerie.dz/news/fr/article/20150425/38291.html

Download references

Author information

Authors and Affiliations

  1. Pharmacy Department, Université Saad Dahlab de Blida, Blida, 09000, Algeria

    M. Chekiri-Talbi

  2. The University of Manchester, National Aspergillosis Centre, University Hospital of South Manchester and Manchester Academic Health Science Centre, Manchester, UK

    D. W. Denning

Authors
  1. M. Chekiri-Talbi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. W. Denning
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Chekiri-Talbi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chekiri-Talbi, M., Denning, D.W. Burden of fungal infections in Algeria. Eur J Clin Microbiol Infect Dis 36, 999–1004 (2017). https://doi.org/10.1007/s10096-017-2917-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-017-2917-8

Keywords

Search

Navigation